SCHEMBL754885

SCHEMBL754885

COC(=O)c1cnc(Oc2ccc(Cl)c([C@@H](C)[C@@](O)(c3ccnc(Cl)c3)C(F)(F)F)c2)nc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.36
ABL1 P00519 1/20 0.35
LMNA P02545 1/20 0.34
P2RX3 P56373 1/20 0.34
RAF1 P04049 2/20 0.33
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
BDKRB1 P46663 1/20 0.32
S1PR4 O95977 1/20 0.32
S1PR3 Q99500 1/20 0.32
PDK1 Q15118 2/20 0.32
PDK2 Q15119 2/20 0.32
PDK3 Q15120 2/20 0.32
PDK4 Q16654 2/20 0.32
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
ROCK2 O75116 2/20 0.32
PRKG1 Q13976 1/20 0.32
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL480025 1.00 KDR (0.36) KDRABL1LMNAP2RX3RAF1
SCHEMBL479658 0.93 KDR (0.34) KDRABL1LMNAP2RX3RAF1
SCHEMBL753032 0.91 THRA (0.35) KDRABL1P2RX3RAF1KMT2A
SCHEMBL479959 0.91 THRA (0.35) KDRABL1P2RX3RAF1KMT2A
SCHEMBL15789721 0.90 ROCK2 (0.33) KDRABL1LMNARAF1KMT2A
SCHEMBL479929 0.90 LMNA (0.46) KDRLMNAP2RX3S1PR4S1PR3
SCHEMBL755575 0.90 LMNA (0.46) KDRLMNAP2RX3S1PR4S1PR3
SCHEMBL15789808 0.87 RAF1 (0.31) KDRRAF1KMT2AROCK2PRKG1
SCHEMBL753033 0.84 P2RX3 (0.35) KDRLMNAP2RX3RAF1KMT2A
SCHEMBL479989 0.84 P2RX3 (0.35) KDRLMNAP2RX3RAF1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2411361-B1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2014-06-18 EP disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
WO-2010108902-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2010-09-30 WO disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 KDR 733/4885ABL1 2718/4885LMNA 1995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.